Timing of ganciclovir administration in glioma gene therapy using HSVtk gene-transduced mesenchymal stem cells

Cancer Genomics and Proteomics

Volumn 8, Issue 5, 2011, Pages 245-250

  Amano, Shinji ^a   Gu, Chunyu ^a,b   Koizumi, Shinichiro ^a   Tokuyama, Tsutomu ^a   Namba, Hiroki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Ganciclovir; Glioma; Herpes simplex virus thymidine kinase; Mesenchymal stem cells; Suicide gene therapy

Indexed keywords

GANCICLOVIR; HERPES SIMPLEX VIRUS THYMIDINE KINASE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BYSTANDER EFFECT; CANCER GENE THERAPY; CONTROLLED STUDY; GLIOMA; MALE; MESENCHYMAL STEM CELL; NONHUMAN; RAT; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE;

ANIMALIA; SIMPLEXVIRUS;

EID: 80054690010     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. DeAngelis LM: Brain tumors. N Engl J Med 344: 114-123, 2001.
2. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359: 1011-1018, 2002.
3. Culver KW, Ram Z, Walbridge S, Ishii H, Oldfield EH and Blaese RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550-1552, 1992.
4. Amano S, Li S, Gu C, Gao Y, Koizumi S, Yamamoto S, Terakawa S and Namba H: Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy. Int J Oncol 35: 1265-1270, 2009.
5. Amano S, Gu C, Koizumi S, Tokuyama T and Namba H: Tomoricidal bystander effect in the suicide gene therapy using mesenchymal stem cells does not injure normal brain tissues. Cancer Lett 2011.
6. Bexell D, Gunnarsson S, Tormin A, Darabi A, Gisselsson D, Roybon L, Scheding S and Bengzon J: Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 17: 183-190, 2009.
7. Lee J, Elkahloun AG, Messina SA, Ferrari N, Xi D, Smith CL, Cooper R, Albert PS and Fine HA: Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellular vector. Cancer Res 63: 8877-8889, 2003. (Pubitemid 38064068)
8. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M and Lang FF: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318, 2005. (Pubitemid 40524615)
9. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y and Hamada H: Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11: 1155-1164, 2004. (Pubitemid 39117311)
10. Wu X, Hu J, Zhou L, Mao Y, Yang B, Gao L, Xie R, Xu F, Zhang D, Liu J and Zhu J: In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation. J Neurosurg 108: 320-329, 2008. (Pubitemid 351213297)
11. Yuan X, Hu J, Belladonna ML, Black KL and Yu JS: Interleukin-23- expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res 66: 2630-2638, 2006.
12. Iwadate Y, Namba H, Tagawa M, Takenaga K, Sueyoshi K and Sakiyama S: In vivo bystander effect in the intracranial model with rat glioma cells reflects the clonal difference of HSV-TK positive cells. Int J Oncol 9: 521-525, 1996. (Pubitemid 26323945)
13. Rainov NG: A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11: 2389-2401, 2000.
14. Ram Z, Culver KW, Oshiro EM, Viola JJ, DeVroom HL, Otto E, Long Z, Chiang Y, McGarrity GJ, Muul LM, Katz D, Blaese RM and Oldfield EH: Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 3: 1354-1361, 1997. (Pubitemid 28011035)
15. Kinoshita Y, Kamitani H, Mamun MH, Wasita B, Kazuki Y, Hiratsuka M, Oshimura M and Watanabe T: A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells. Neurol Res 2009.
16. Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N and Namba H: Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther 12: 600-7, 2005. (Pubitemid 40967220)
17. Miletic H, Fischer YH, Litwak S, Giroglou T, Waerzeggers Y, Winkeler A, Li H, Himmelreich U, Lange C, Stenzel W, Deckert M, Neumann H, Jacobs AH and vonLaer D: Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther 15: 1373-1381, 2007. (Pubitemid 46965333)
18. Ribot E, Bouzier-Sore AK, Bouchaud V, Miraux S, Delville MH, Franconi JM and Voisin P: Microglia used as vehicles for both inducible thymidine kinase gene therapy and MRI contrast agents for glioma therapy. Cancer Gene Ther 14: 724-737, 2007. (Pubitemid 47080362)
19. Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A and Ozawa K: Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy. J Gene Med 11: 373-381, 2009.
20. Li S, Gao Y, Tokuyama T, Yamamoto J, Yokota N, Yamamoto S, Terakawa S, Kitagawa M and Namba H: Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Cancer Lett 251: 220-227, 2007. (Pubitemid 46669798)
21. Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N and Namba H: Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene. Oncology 69: 503-508, 2005.
22. Jacobs AH, Winkeler A, Hartung M, Slack M, Dittmar C, Kummer C, Knoess C, Galldiks N, Vollmar S, Wienhard K and Heiss WD: Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron-emission tomography marker and therapeutic genes. Hum Gene Ther 14: 277-297, 2003. (Pubitemid 36423446)
23. Miletic H, Fischer YH, Giroglou T, Rueger MA, Winkeler A, Li H, Himmelreich U, Stenzel W, Jacobs AH and von Laer D: Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma. Clin Cancer Res 13: 6761-6768, 2007. (Pubitemid 350206814)
24. Roelants V, Labar D, de Meester C, Havaux X, Tabilio A, Gambhir SS, Di Ianni M, Bol A, Bertrand L and Vanoverschelde JL: Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells. J Nucl Med 49: 1836-1844, 2008.
25. Xiong Z, Cheng Z, Zhang X, Patel M, Wu JC, Gambhir SS and Chen X: Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med 47: 130-139, 2006. (Pubitemid 46768522)
26. Yaghoubi SS, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Herschman HR and Gambhir SS: Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Ther 12: 329-339, 2005. (Pubitemid 40315193)
27. Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine HA and Frank JA: Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105: 420-425, 2005. (Pubitemid 40053114)
28. Farrell E, Wielopolski P, Pavljasevic P, van Tiel S, Jahr H, Verhaar J, Weinans H, Krestin G, O'Brien FJ, van Osch G and Bemsen M: Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun 369: 1076-1081, 2008.
29. Zhang Z, Jiang Q, Jiang F, Ding G, Zhang R, Wang L, Zhang L, Robin AM, Katakowski M and Chopp M: In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage 23: 281-287, 2004. (Pubitemid 39119458)